Published in Drug Week, November 26th, 2004
[helv]Chiron profoundly regrets that it is unable to meet the public health needs for the current influenza season. The company is committed to resolving the concerns raised by regulatory authorities in the United Kingdom and the United States.
The company expects to work closely with both the U.K. regulatory body,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.